The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
Christian Mayr(Paracelsus Medical University), Tobias Kiesslich(Paracelsus Medical University)
Cited by 42
Related Papers
Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells
|International Journal of Molecular Sciences|2018|53
Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients
|International Journal of Molecular Sciences|2016|17